Kidney Cancer Trials

Suzanne Chambers discusses Clinical Trials

The aim of this study is to determine the activity and safety of pembrolizumab and denosumab in advanced clear cell Renal Cell Carcinoma (ccRCC). 

A Phase II Trial Of Single Agent Cabozantinib In Patients With Locally Advanced Or Metastatic Non-Clear Cell Renal Cell Carcinoma Post Immunotherapy Or Who Are Unsuitable For Immunotherapy.  

This study is for adults with non-clear cell Renal Cell Carcinoma (m-n-ccRCC). This trial is now in follow up.
FASTRACK II is a co-badged trials and aims to estimate the efficacy of SABR for primary Renal Cell Carcinoma (RCC). This trial is now in follow up.
© ANZUP 2021. All rights reserved.